INTERNATIONAL AIDS MEDICATIONS
Save up to 80% on
International HIV/AIDS Prescription Drugs
More affordable quality HIV/AIDS medicines Now Available
call today for a confidential, no obligation quote...
Low Cost International AIDS Medications Discount Prices
HIV left untreated becomes AIDS. AIDS is 100% fatal, However, life-prolonging antiretroviral drugs have begun to transform HIV from an inescapable death sentence into a manageable condition for those, primarily living in developed countries who are able to purchase them. We help people with HIV/AIDS to "confidentially" get more affordable medications from proven international medication sources. Call now toll free for a free, no obligation quote (888) 380-6337.
HIV/AIDS
Medication Price List
Prices Updated (3/27/08)
HIV has imperiled the very fabric of human society as no disease in human history has before. By 2010, it is estimated that deaths from the pandemic will rival those of the bubonic plague, which killed 93 million people. The numbers may be staggering, but we cannot afford to let them become numbing. Evidence of successes in lowering the incidence of infection in countries such as Thailand and Uganda indicate that curbing the HIV/AIDS pandemic is not hopeless. A unified and global commitment to turning the tide on this disease is needed and is building. This effort will require effective use of sufficient resources devoted to research, prevention, care and treatment for those infected with and affected by the disease.
By the end of 2003, there were 37.8 million people living with HIV/AIDS, including 17 million women and 2.1 million children under the age of 15. 4.8 million people were newly infected with HIV in 2003, including 630,000 children. In 2003 alone, a total of 2.9 million people died of HIV/AIDS-related causes. UNAIDS predicts that an additional 45 million people will become infected with HIV in 126 low-and middle-income countries by 2010, unless the world succeeds in mounting a drastically expanded, global prevention effort.
By the end of 2003, women accounted
for nearly half of all people living with AIDS worldwide, and represent almost
60% of infections in sub-Saharan Africa. Moreover, young women are several times
more likely than young men to contract the disease through heterosexual contact.
Worldwide, 62% of infected young people are girls, and that number soars to 75%
in sub-Saharan Africa. A woman’s vulnerability to the virus is attributable not
only to biological differences, but also to deeply entrenched socio-economic
inequalities that further compound her risk.
Because 70% of the world’s poor are women, women have fewer economic options.
They are far more vulnerable to engaging in transactional sex to pay for food,
school fees and other necessities. They are also vulnerable to coercive or
forced sex and often unable to negotiate condom use.
Many women, particularly married women, cannot control the circumstances under
which sex takes place. Women are especially unable to negotiate sex or condom
use with a husband who may have extramarital partners. Some research indicates
that married women are in fact more at risk for HIV than unmarried women because
they are more frequently exposed to intercourse within marriage.
HIV-positive women may transmit HIV to their children during pregnancy, in
childbirth or through breastfeeding. Today, mother-to-child transmission (MTCT)
of HIV is the primary mode of acquisition of HIV for the more than 2 million
children living with HIV. While antiretroviral therapy significantly reduces the
risk of MTCT of HIV, only 1% of women in need currently have access to this
preventive therapy.
As AIDS ravages families and communities, the burden of caring for ill family
members rests mainly with women and girls — many of whom may be seriously ill
themselves. A woman affected by HIV/AIDS is plunged further into poverty, losing
the ability to provide for herself and her children. Combined with pervasive
social stigma and the collapse of traditional family and support structures,
HIV/AIDS is eroding the status of women in many countries.
Epivir
Epivir...Epivir is an anti-HIV medication. It is in a category of HIV medications called nucleoside reverse transcriptase inhibitors (NRTIs). Epivir prevents HIV from altering the genetic material of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Epivir, manufactured by GlaxoSmithKline, was approved for the treatment of HIV by the U.S. Food and Drug Administration (FDA) in 1995. Epivir is also approved for the treatment of chronic hepatitis B infection (Epivir HBV). The Epivir dose normally used to treat hepatitis B is one 100mg tablet once a day. The dose used to treat HIV is one 300mg tablet once a day, or one 150mg tablet every 12 hours. If you are infected with both HIV and hepatitis B, it is important that you take the dose used to treat HIV. Epivir must be used in combination with at least two other anti-HIV drugs. For more information see http://www.aidsmeds.com/drugs/Epivir.htm
Combivir
Combivir...Combivir is an anti-HIV medication. It is in a category of HIV medicines called nucleoside reverse transcriptase inhibitors (NRITs). Combivir prevents HIV from altering the genetic material of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Combivir is marketed by GlaxoSmithKline. It was approved by the U.S. Food and Drug Administration (FDA) for use by people living with HIV in 1997. Combivir is a combination of two drugs: 300mg of Retrovir® (AZT) and 150mg of Epivir® (3TC). Combivir should be prescribed by a healthcare provider for patients who need both of these drugs. Both of these drugs can still be purchased individually for use in combination with other anti-HIV drugs. Combivir must be combined with at least one other anti-HIV drug. For more information see http://www.aidsmeds.com/drugs/Combivir.htm
Crixivan
Crixivan...Crixivan is an anti-HIV medication. It is in a category of HIV medications called protease inhibitors (PIs). Crixivan prevents T-cells that have been infected with HIV from producing new HIV. Crixivan, manufactured by Merck & Company, was approved for the treatment of HIV by the U.S. Food and Drug Administration (FDA) in 1996. Crixivan must be used in combination with at least two other anti-HIV drugs. For more information see http://www.aidsmeds.com/drugs/Crixivan.htm
Fortovase
Fortovase...Fortovase is an anti-HIV medication. It is in a category of HIV medications called protease inhibitors (PIs). Fortovase prevents T-cells that have been infected with HIV from producing new HIV. Fortovase is manufactured by Hoffmann-La Roche. The U.S. Food and Drug Administration (FDA) approved it for the treatment of HIV infection in 1997. Fortovase is a newer version of saquinavir, the generic name for this protease inhibitor. The first version of saquinavir, Invirase®, was approved in 1995. Hoffmann-La Roche will be stopping production of Fortovase in 2006. Invirase will be the only form of saquinavir available after this time. This is because the 500mg capsules of Invirase, combined with ritonavir, are better tolerated than the current Fortovase capsules (combined with ritonavir). For more information see http://www.aidsmeds.com/drugs/Fortovase.htm
Invirase
Invirase...Invirase is an anti-HIV medication. It is in a category of HIV medications called protease inhibitors (PIs). Invirase prevents T-cells that have been infected with HIV from producing new HIV. Invirase is manufactured by Hoffmann-La Roche. The U.S. Food and Drug Administration (FDA) approved it for the treatment of HIV infection in 1995. Invirase should be taken with low doses of Norvir® (ritonavir), another protease inhibitor that boosts Invirase levels in the body (Invirase suffers from absorption problems, meaning that only a small amount of the drug is absorbed into the bloodstream from the gut). Invirase (1,000mg twice daily) combined with Norvir (100mg twice daily) was approved by the FDA in December 2003 for this purpose. As an alternative, people can take Fortovase either with or without low-dose Norvir. Invirase, combined with Norvir, is just as effective as Fortovase combined with Norvir. For more information see http://www.aidsmeds.com/drugs/Invirase.htm
Retrovir
Retrovir...Retrovir is an anti-HIV medication. It is in a category of HIV medications called nucleoside reverse transcriptase inhibitors (NRTIs). Retrovir prevents HIV from altering the genetic material of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Retrovir, manufactured by GlaxoSmithKline, was the first drug approved for the treatment of HIV, in 1987. Retrovir must be used in combination with at least two other anti-HIV drugs. For more information see http://www.aidsmeds.com/drugs/Retrovir.htm
Sustiva
Sustiva...Sustiva is an anti-HIV medication. It is in a category of HIV medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs). Sustiva prevents HIV from entering the nucleus of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Sustiva was approved by the U.S. Food and Drug Administration for the treatment of HIV in 1998. It was originally produced by DuPont Pharmaceuticals and is now manufactured by Bristol-Myers Squibb for sale in the United States. In Europe and many other parts of the world, Sustiva has a different brand name: Stocrin®. Stocrin is manufactured by by Merck Sharp and Dohme. Stocrin and Sustiva are the same drug. Sustiva must be used in combination with other drugs to treat HIV. It is usually combined with two nucleoside analogues. For more information see http://www.aidsmeds.com/drugs/Sustiva.htm
Viracept
Viracept...Viracept is an anti-HIV medication. It is in a category of HIV medications called protease inhibitors (PIs). Viracept prevents T-cells that have been infected with HIV from producing new HIV. Viracept is manufactured by Agouron Pharmaceuticals, a division of Pfizer Inc. The U.S. Food and Drug Administration (FDA) approved it for the treatment of HIV infection in 1997. For more information see http://www.aidsmeds.com/drugs/Viracept.htm
Viramune
Viramune...Viramune is an anti-HIV medication. It is in a category of HIV medicines called non-nucleoside reverse trancriptase inhibitors (NNRTIs). Viramune prevents HIV from entering the nucleus of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Viramune, manufactured by Boehringer-Ingelheim, was approved by the U.S. Food and Drug Administration for the treatment of HIV in 1996. Viramune must be used in combination with other drugs to treat HIV. It is usually combined with two nucleoside analogues. For more information see http://www.aidsmeds.com/drugs/Viramune.htm
Zerit
Zerit...Zerit is an anti-HIV medication. It is in a category of HIV medications called nucleoside reverse transcriptase inhibitor (NRTIs). Zerit prevents HIV from altering the genetic material of healthy T-cells. This prevents the cells from producing new virus and decreases the amount of virus in the body. Zerit, manufactured by Bristol-Myers Squibb, was approved by the U.S. Food and Drug Administration for the treatment of HIV in 1994. Zerit must be used in combination with at least two other anti-HIV drugs. For more information see http://www.aidsmeds.com/drugs/Zerit.htm
Key words: Low Cost International AIDS Medications, AIDS Prescription Drugs, AIDS Medicines, Discount AIDS Prescription Drugs, Discounted International AIDS Medications, Affordable AIDS Medications, Low Cost Epivir, Discount Epivir, Epivir Discounts, Low Cost Combivir, Combivir Discounts, International Combivir, low cost crixivan, crixivan discounts, discounted crixivan, international crixivan, Canadian pharmacies, Canadian AIDS medications, AIDS medicines from Canada, low cost fortovase, fortovase discounts, international fortovase, low cost hivid, hivid discounts, discounted hivid, low cost invirase, invirase discounts, discounted invirase, international invirase, prices, medicines, costs, discounts, low cost retrovir, retrovir discounts, discounted retrovir, international retrovir, AIDS medicines, AIDS medications, low cost AIDS prescription drugs prices, AIDS medicines costs, low cost sustiva, discounted sustiva, sustiva discounts, low cost videx, videx discounts, videx prices, low cost AIDS medications, low cost viracept, international viracept, discounted viracept, viracept discounts, low cost viramune, viramune discounts, international viramune, viramune prices, low cost zerit, discounted zerit prices, international zerit discounts.
